Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00670111 · ClinicalTrials.gov registry record · NA
Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction
A NA study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT00670111 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 32 participants.
The verdict
NCT00670111, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
This study will look at how pacing your heart may assist your daily activities and how you are feeling.
Interventions
- DEVICE Insignia Plus / Ultra (Guidant/Boston Scientific)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00670111
The ClinicalTrials.gov registry entry for NCT00670111 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Insignia Plus / Ultra (Guidant/Boston Scientific) is the first listed.
NCT00670111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00670111 about?
NCT00670111 is a clinical study titled "Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction". This study will look at how pacing your heart may assist your daily activities and how you are feeling.
What is the current status of trial NCT00670111?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2008-07. Estimated completion is 2011-07.
What interventions are being tested in trial NCT00670111?
The interventions under investigation include: Insignia Plus / Ultra (Guidant/Boston Scientific) (DEVICE).
Who is sponsoring clinical trial NCT00670111?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.